Pharmacist Evaluating Examination sample question MCQs PART 2
Categories: WORLD EDUATION NEWS
Pharmacist Evaluating Examination sample question PART 2
Q16 is marketed as Tavanic
A ❏ nalidixic acid
B ❏ norfloxacin
C ❏ levofloxacin
D ❏ ofloxacin
E ❏ amphotericin
Q17 is only indicated in urinary tract infection
A ❏ nalidixic acid
B ❏ norfloxacin
C ❏ levofloxacin
D ❏ ofloxacin
E ❏ amphotericin
Q18 may cause intrauterine growth restriction
A ❏ atenolol
B ❏ folic acid
C ❏ imipramine
D ❏ carbamazepine
E ❏ co-trimoxazole
Q19 may increase the risk of neural tube defects
A ❏ atenolol
B ❏ folic acid
C ❏ imipramine
D ❏ carbamazepine
E ❏ co-trimoxazole
Q20 may increase the risk of tachycardia in neonate
A ❏ atenolol
B ❏ folic acid
C ❏ imipramine
D❏ carbamazepine
E ❏ co-trimoxazole